| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |